AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
#202 – Rick Doblin: Psychedelics
Lex Fridman Podcast
Phase 3 - Is There a Double Blind?
The FDA and the European Medicines Agency agreed that the best design was therapy with inactive placebo versus therapy with full dose MDMA. Most therapists will be able to tell the difference, but that makes a harder test for us to show a difference between the two groups. The paper in Nature Medicine that just came out was the results of our first Phase 3 study.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode